Laboratory Compliance
PRESS RELEASE THE DARK REPORT 21806 Briarcliff Dr. Spicewood, Texas 78669 512-264-7103 o 512-264-0969 f FOR IMMEDIATE RELEASE Media Contact: Chris Garcia chris@darkreport.com AUSTIN, Texas (January 16, 2017) It is...
In 2010, results of a phase 3 randomized controlled trial showed that targeted therapy directed against HER2 statistically significantly prolonged overall survival compared with chemotherapy alone in patients with HER2–positive...
I received a lot of feedback offline about Part 1 of this post (see: “To Sign Out or Not to Sign Out? Part 1” ) from a number of pathologists echoing my sentiments on the issue of turnaround time in general and needs/expectations from...
That is the question. Every year. Around the holidays or three-day weekends. Normally biopsies or surgical specimens collected the day before are reviewed the next day. In a majority of cases, the case can be “signed out” meaning your...
medpagetoday.com posted a brief but concise article earlier this week on the issue of FDA regulating laboratory developed tests (LDTs). While the FDA has had the ability to regulate these tests since 1976, largely once regarded as "simple and...
Enabling Economical Digital Pathology Transformation for Next-gen Diagnostic Accuracy in AP San Diego, CA -- October 25, 2016 -- Mikroscan Technologies, Inc. Mikroscan announced today it has entered into an agreement with QualityStar, LLC., a...
